Patents Assigned to Panda Pharmaceuticals, L.L.C.
  • Composition and method for treatment of psoriasis
    Patent number: 5990100
    Abstract: Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: November 23, 1999
    Assignees: Panda Pharmaceuticals, L.L.C., The University of Tennessee Research Corporation
    Inventors: E. William Rosenberg, Thomas M. Glenn, Robert B. Skinner, Jr., Patricia W. Noah
  • Composition and method for treatment of psoriasis
    Patent number: 5886038
    Abstract: A pharmaceutical composition for use in the treatment of psoriasis, having isopropyl myristate as its only active ingredient.
    Type: Grant
    Filed: March 24, 1998
    Date of Patent: March 23, 1999
    Assignees: Panda Pharmaceuticals, L.L.C., The University of Tennessee Research Corporation
    Inventors: Thomas M. Glenn, E. William Rosenberg, Robert B. Skinner, Jr., Patricia W. Noah